U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9816198161Staying Active With ArthritisActive, not recruitingNo Results AvailableOsteoarthritis, Knee|HypertensionBehavioral: STAR Intervention|Behavioral: Attention-Controlhttps://ClinicalTrials.gov/show/NCT01280903
9816298162Person- Centred Care Among Nursing Home Patients With DementiaCompletedNo Results AvailableDementia|AgitationBehavioral: Staff training using VIPS|Behavioral: Staff training using DCM|Behavioral: Control grouphttps://ClinicalTrials.gov/show/NCT01280890
9816398163Paraorbital-Occipital Alternating Current Stimulation Therapy for Optic Neuropathy (MCT_optnerve)CompletedNo Results AvailableOptic Nerve Diseases|Optic Nerve Injuries|Optic NeuropathiesDevice: tACS|Device: Sham stimulationhttps://ClinicalTrials.gov/show/NCT01280877
9816498164MAPP Investigation of Pelvic Floor-Brain Neurobiologic Axis in IC/IBS and IBSTerminatedNo Results AvailableInterstitial Cystitis|Irritable Bowel Syndromehttps://ClinicalTrials.gov/show/NCT01280864
9816598165Living Renal Donor MRI StudyWithdrawnNo Results AvailableLiving Renal DonorProcedure: Magnetic Resonance Imaginghttps://ClinicalTrials.gov/show/NCT01280851
9816698166Safer Sex Intervention for Male Clients of Female Sex Workers in Tijuana, MexicoCompletedNo Results AvailableHIV|Sexually Transmitted DiseasesBehavioral: Hombre Seguro|Behavioral: Didactic attention-control conditionhttps://ClinicalTrials.gov/show/NCT01280838
9816798167The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic TestingRecruitingNo Results AvailablePatients Undergoing Routine Health Care|Heart Diseases|Inflammatory Bowel Diseases|Autoimmune Disease|Inflammatory Disease|Blood Coagulation Disorders|Hepatitis C|Non-Metastatic Neoplasmhttps://ClinicalTrials.gov/show/NCT01280825
9816898168Applying Mobile Persuasive Technologies to Increase Physical Activity in WomenCompletedNo Results AvailableSedentary Lifestyle|Physical ActivityBehavioral: Mobile phone based physical activity intervention with maintenance plus|Behavioral: Mobile phone based physical activity intervention with maintenance regular|Behavioral: Pedometer onlyhttps://ClinicalTrials.gov/show/NCT01280812
9816998169Family Treatment for Adolescents With Anorexia NervosaCompletedNo Results AvailableAnorexia Nervosa|Subthreshold Anorexia Nervosa|Eating Disorder Not Otherwise Specified, Primarily RestrictionBehavioral: Acceptance-based separated family treatmenthttps://ClinicalTrials.gov/show/NCT01280799
9817098170Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid LeukemiaActive, not recruitingNo Results AvailableAcute Myeloid LeukemiaDrug: Elesclomol Sodiumhttps://ClinicalTrials.gov/show/NCT01280786
9817198171Effect of NAVA on Duration of Weaning in Difficult to Wean PatientsRecruitingNo Results AvailableWeaningDevice: Neurally adjusted ventilatory assisthttps://ClinicalTrials.gov/show/NCT01280773
9817298172Impact of Neurally Adjusted Ventilator Assist (NAVA) Mode on Patient Ventilator Asynchrony Using Non-invasive Ventilation (NAVA-NIV)CompletedNo Results AvailableWeaning PeriodOther: Device: Neurally Adjusted Ventilatory Assistancehttps://ClinicalTrials.gov/show/NCT01280760
9817398173Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND StudyTerminatedNo Results AvailableFibromyalgia|Painful Diabetic Peripheral NeuropathyOther: prior authorization|Other: no prior authorization|Other: prior authorization|Other: no prior authorizationhttps://ClinicalTrials.gov/show/NCT01280747
9817498174Investigation of Melatonin and Zolpidem Effect on Postural Instability in Healthy Adult SubjectsCompletedNo Results AvailablePostural InstabilityDrug: Circadin (R) 2 mg|Drug: Stilnox (R) 10 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01280734
9817598175A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan]Active, not recruitingNo Results AvailableAutosomal Dominant Polycystic Kidney Disease (ADPKD)Drug: tolvaptanhttps://ClinicalTrials.gov/show/NCT01280721
9817698176Protocol DIVAT-UroRecruitingNo Results AvailableKidney Transplantation|Pancreas-kidney TransplantationOther: Capture datahttps://ClinicalTrials.gov/show/NCT01280708
9817798177A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic PatientsCompletedHas ResultsDiabetes Mellitus, Type 2Drug: Placebo|Drug: MSDC-0602 100 mg|Drug: MSDC-0602 250 mg|Drug: MSDC-0602 250 mg|Drug: Pioglitazonehttps://ClinicalTrials.gov/show/NCT01280695
9817898178Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 DiabetesRecruitingNo Results AvailableDiabetes Mellitus, Type 1Drug: rituximabhttps://ClinicalTrials.gov/show/NCT01280682
9817998179Intravitreal Sirolimus as Therapeutic Approach to UveitisNot yet recruitingNo Results AvailableUveitis|Intermediate Uveitis|Posterior Uveitis|PanuveitisDrug: Intravitreal injection 440mcg|Drug: Intravitreal injection of sirolimus 880mcghttps://ClinicalTrials.gov/show/NCT01280669
9818098180A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)CompletedNo Results AvailableHepatitis C, Chronichttps://ClinicalTrials.gov/show/NCT01280656
9818198181Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal CancerCompletedNo Results AvailableMetastatic Colorectal CancerDrug: fluorouracil|Drug: leucovorin calcium|Drug: oxaliplatin|Drug: irinotecan hydrochloride|Biological: bevacizumab|Biological: cetuximab|Drug: capecitabine|Genetic: mutation analysis|Genetic: gene expression analysis|Other: laboratory biomarker analysis|Other: immunohistochemistry staining method|Genetic: nucleic acid sequencing|Genetic: protein expression analysis|Genetic: polymerase chain reaction|Genetic: DNA analysishttps://ClinicalTrials.gov/show/NCT01280643
9818298182Multicentre Retrospective Study to Understand Anti-thrombotic Treatment Patterns and Outcomes of Acute Coronary Syndrome (ACS) PatientsCompletedNo Results AvailableAcute Coronary Syndromehttps://ClinicalTrials.gov/show/NCT01280630
9818398183Low Dose Thymoglobin in Renal Transplant PatientsCompletedNo Results AvailableAcute Renal FailureDrug: Thymoglobulin|Drug: Thymoglobulin 0.75mg/kg dosehttps://ClinicalTrials.gov/show/NCT01280617
9818498184Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin TherapyCompletedHas ResultsHyperlipidemiasDrug: Fenofibrate 54mghttps://ClinicalTrials.gov/show/NCT01280604
9818598185Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental PainCompletedHas ResultsPain, PostoperativeDrug: Naproxen sodium 440 mg / DPH 50 mg (BAY98-7111)|Drug: Naproxen sodium 220 mg / DPH 50 mg (BAY98-7111)|Drug: Naproxen sodium 440 mg (BAYH6689)|Drug: DPH 50 mghttps://ClinicalTrials.gov/show/NCT01280591
9818698186The Coherex FlatStentâ„¢ EF PFO Migraine RegistryNot yet recruitingNo Results AvailablePatients With Migraine and PFODevice: Transcatheter PFO Closurehttps://ClinicalTrials.gov/show/NCT01280578
9818798187A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Dacarbazine in the Treatment of Patients With Non-Resectable or Metastatic Stage 3 or Stage 4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of C-KitRecruitingNo Results AvailableMetastatic MelanomaDrug: masitinib|Drug: Dacarbazinehttps://ClinicalTrials.gov/show/NCT01280565
9818898188A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)Active, not recruitingHas ResultsGlioblastoma MultiformeBiological: ICT-107|Biological: Placebo DChttps://ClinicalTrials.gov/show/NCT01280552
9818998189The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Multiple SclerosisCompletedNo Results AvailableMultiple SclerosisDevice: Transcutaneous electrical nerve stimulationhttps://ClinicalTrials.gov/show/NCT01280539
9819098190A Study of Escalating Doses of Romidepsin in Association With CHOP in the Treatment of Peripheral T-Cell LymphomasCompletedNo Results AvailablePeripheral T Cell LymphomaDrug: Romidepsin and CHOP|Drug: Romidepsin and CHOP|Drug: Romidepsin and CHOP|Drug: Romidepsin and CHOPhttps://ClinicalTrials.gov/show/NCT01280526

* Görseller ve İçerik tekif hakkına sahip olabilir